4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]pyrimidin-7-ylamino]-N,N-dimethylbenzenesulfonamide

4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]pyrimidin-7-ylamino]-N,N-dimethylbenzenesulfonamide is an experimental small molecule compound belonging to the benzenesulfonamide class. It has a molecular formula of C23H33N7O2S and a molecular weight of approximately 471.6 g/mol. The compound is structurally characterized by a pyrazolopyrimidine core with an aminocyclohexyl substituent and a dimethylbenzenesulfonamide group. While detailed pharmacological data are limited, it has been identified as interacting with protein kinase C eta (PRKCH) and cyclin-dependent kinase 2 (CDK2), suggesting potential activity as a kinase inhibitor. Its primary mechanism appears to involve inhibition of these kinases, which are relevant in cell cycle regulation and signal transduction pathways[1][2]. The drug is currently classified as experimental with no approved therapeutic indications.